Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00123188
Status:
TERMINATED
Last Update Posted:
2015-01-19
First Post:
2005-07-20
Brief Title:
Ultrasound and Endometrial Hyperplasia
Sponsor:
Milton S Hershey Medical Center
Organization:
Milton S Hershey Medical Center
Study Overview
Official Title:
Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
Status:
TERMINATED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
enrollment of participants has halted prematurely difficulty with recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome diabetes andor insulin resistance hypertension and obesity
Detailed Description:
The objective is to identify the utility of ultrasound as a screening test for endometrial hyperplasia and cancer in an at risk cohort Endometrial carcinoma is an understudied cancer This study will provide benefit regardless of its outcome because it will be the first prospectively designed screening trial in an asymptomatic population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None